Clinical trial

Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments

NCT06448793

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2024-11-25

PhaseN/A

Study timeline

Study start (actual)2024-11-25Date precision: day

Registry last updated2026-08-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-small Cell Lung Cancer (NSCLC)unresolved

Interventions

Approved Non-small Cell Lung Cancer (NSCLC) therapiesDRUG

Sponsors & collaborators

Bristol-Myers Squibblead sponsor

Mapped research locations

LondonUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06448793 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.